Conditions: Carcinoma, Small Cell Small Cell Lung Cancer
Keywords: Lung Squamous Cell Small Cell Carcinoma Cancer Small Cell Lung Cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 55
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the objective tumor response rate to SNS-595 in patients with small cell lung cancer (SCLC).

Detailed description:
Other objectives of this study are to assess the safety, survival rate, best response, time to disease progression, duration of tumor response, and to explore several potential biomarkers to see how these levels change after administration of SNS-595.

Arms:
arm 1: SNS-595; 48 mg/m2 administered IV once every 21 days for up to 6 cycles.

Interventions: intervention 1: SNS-595
Intervention descriptions: intervention 1: None

Protocol document: